Archives
-
PD 173074: An Epigenetics-Aware FGFR Assay Strategy
2026-09-03
PD 173074 enables precise investigation of FGFR1 and VEGFR2 signaling, but response can depend on cellular epigenetic context. This guide translates HNSCC methylation findings into a practical, target-engagement-focused assay strategy.
-
MG-132 and TDP-43 Aggregation: Assay Logic
2026-09-03
MG-132 (Z-LLL-al) is more than an apoptosis reagent: it can expose how proteasome impairment reshapes TDP-43 aggregation and localization. This article translates the key findings of a 2023 EMBO Journal study into practical assay-design decisions for neurobiology and cancer research.
-
Brefeldin A: Reliable ER Stress Assays
2026-09-02
This scenario-driven guide explains how Brefeldin A, SKU B1400, can improve the interpretation of cell viability, proliferation, cytotoxicity, and protein-trafficking experiments. It connects dose and solvent planning with ER-stress biology, apoptosis, and practical vendor-selection criteria.
-
Aztreonam: Mechanism and Research Evidence
2026-09-02
Aztreonam is a monocyclic β-lactam antibiotic with selective activity against Gram-negative aerobic bacteria. Its research profile combines inhibition of bacterial cell wall synthesis with documented effects on bone marrow progenitor cells and liver cytochrome P450 enzymes.
-
Praeruptorin A: From Target Lists to Translation
2026-09-01
Praeruptorin A is an angular pyranocoumarin compound with a translationally relevant profile spanning iron overload, inflammation, epithelial barrier repair, metastatic behavior, and doxorubicin-associated cardiac injury. This thought-leadership guide shows how to convert those mechanisms into rigorous, decision-oriented research programs.
-
Digoxin: A Mechanism-First Research Framework
2026-09-01
Digoxin is a Na+/K+ ATPase pump inhibitor whose effects span calcium handling, contractility, and cell-specific antiviral phenotypes. This mechanism-first guide shows how to connect target perturbation with assay choice, exposure control, and translational interpretation.
-
Arrb2–6-ketoLCA Signaling in Hepatic IRI
2026-08-31
The reference study identifies hepatocyte Arrb2 as a regulator of hepatic ischemia–reperfusion injury, linking hepatocyte metabolic output to M2 macrophage polarization through 6-ketoLCA. Its combination of clinical samples, hepatocyte-focused mouse genetics, ischemia–reperfusion models, hypoxia–reoxygenation assays, and metabolomics provides a framework for studying macrophage-mediated sterile inflammation.
-
Camptothecin as a Topoisomerase I Inhibitor
2026-08-31
Camptothecin gives cancer researchers a mechanistically defined way to connect topoisomerase I trapping with DNA damage, senescence, apoptosis, and autophagy. This workflow-focused guide shows how to optimize exposure, verify pathway engagement, and extend the compound into experimental-evolution studies without confusing established evidence with forward-looking hypotheses.
-
RepSox for iPSC Platelet Differentiation
2026-08-30
RepSox offers a defined way to probe ALK5-dependent TGF-β signaling during induced pluripotent stem cell workflows. This guide translates recent hiPSC platelet-production advances into a practical RepSox pilot, with controls, readouts, and troubleshooting that distinguish validated findings from testable extensions.
-
Bobcat339 Workflows for TET and DNA Methylation
2026-08-29
Bobcat339 provides a pharmacological way to interrogate TET1- and TET2-dependent DNA demethylation alongside gene-expression and chromatin assays. This practical workflow connects dose-response design with the UHRF1–5-mC–super-enhancer–TGM2 axis reported in senile osteoporosis research.
-
Pomalidomide: A Mutation-Aware Research Strategy
2026-08-28
Pomalidomide and CC-4047 are examined through a mutation-aware framework for multiple myeloma and hematological malignancy research. Learn how genomic heterogeneity, cytokine biology, model selection, and orthogonal readouts can improve interpretation of pomalidomide assays.
-
L-Glutathione Reduced for PDAC Redox Assays
2026-08-28
L-Glutathione Reduced provides a defined thiol control for connecting GOT1-driven metabolism with oxidative-stress readouts in pancreatic cancer models. It also supports practical GST affinity elution and redox-rescue experiments without introducing ethanol or DMSO into aqueous workflows.
-
BRD4770 and the G9a Translational Axis
2026-08-27
BRD4770 offers a practical way to interrogate G9a-dependent H3K9 methylation, senescence, and tumor-cell growth. By connecting product-level evidence in PANC-1 cells with breast cancer findings on the c-MYC–G9a–FTH1 axis, this article outlines a disciplined strategy for translating epigenetic mechanism into testable cancer biology hypotheses.
-
NHS-Biotin for Reliable Protein Labeling
2026-08-27
This scenario-based guide explains how NHS-Biotin (SKU A8002) can strengthen antibody, protein, and intracellular labeling workflows that support viability, proliferation, and cytotoxicity assays. It covers reaction chemistry, compatibility, protocol handling, interpretation, and practical vendor-selection criteria.
-
Cycloheximide for Protein Turnover Assays
2026-08-26
Cycloheximide is a protein biosynthesis inhibitor that can transform apoptosis and protein stability experiments when used as a timed mechanistic perturbation. This guide connects translational control with the PAK1 degradation findings in oesophageal cancer research and provides an assay-centered workflow.